Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ceftriaxone
- Therapeutic area
- Anti-infectives
- Drug class
- Third-generation cephalosporins
- ATC
- J01DD04
- Strength
- 1 g
- Dosage form
- Injection
- Pack
- 1's
- Registration no.
- 018300
- Price record verified
- 2026-08-07
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Hizone 1 g injection
Hizone 1 g injection contains Ceftriaxone 1 g. It is registered with DRAP by HIGH-Q Pharmaceuticals (registration no. 018300). Its official price is PKR 883.61 for a pack of 1's. This price has applied since 18 August 2025. Hizone is also available as 250 mg injection. 75 other brands of Ceftriaxone 1 g (injection) are registered in Pakistan. Compare all brands and prices →
Other strengths of Hizone
Other brands of Ceftriaxone 1 g
Official price over time
No change in the official DRAP price is recorded for this pack (1's). Current price PKR 883.61, effective 18 Aug 2025.
Cite this price history
MedInfoBase. Hizone 1 g, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/hizone-1-g-018300-1s-high-q-international/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 883.61 | 2025-08-18 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 018300Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
